Richard Thomas Layer - Publications

Affiliations: 
InVivo Therapeutics 
Area:
Neuropharmacology, Spinal Cord Injury

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2004 Layer RT, Wagstaff JD, White HS. Conantokins: peptide antagonists of NMDA receptors. Current Medicinal Chemistry. 11: 3073-84. PMID 15579001 DOI: 10.2174/0929867043363901  0.336
2000 Adams AC, Layer RT, McCabe RT, Keefe KA. Effects of conantokins on L-3,4-dihydroxyphenylalanine-induced behavior and immediate early gene expression. European Journal of Pharmacology. 404: 303-13. PMID 10996596 DOI: 10.1016/S0014-2999(00)00640-3  0.334
1998 McCabe RT, Sofia RD, Layer RT, Leiner KA, Faull RL, Narang N, Wamsley JK. Felbamate increases [3H]glycine binding in rat brain and sections of human postmortem brain. The Journal of Pharmacology and Experimental Therapeutics. 286: 991-9. PMID 9694960  0.401
1997 Huang NY, Strakhova M, Layer RT, Skolnick P. Chronic antidepressant treatments increase cytochrome b mRNA levels in mouse cerebral cortex. Journal of Molecular Neuroscience : Mn. 9: 167-76. PMID 9481618 DOI: 10.1007/Bf02800499  0.601
1997 Hill RA, Wallace LJ, Miller DD, Weinstein DM, Shams G, Tai H, Layer RT, Willins D, Uretsky NJ, Danthi SN. Structure--activity studies for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid receptors: acidic hydroxyphenylalanines. Journal of Medicinal Chemistry. 40: 3182-91. PMID 9379437 DOI: 10.1021/Jm950028Z  0.644
1996 Layer RT, Skolnick P, Bertha CM, Bandarage UK, Kuehne ME, Popik P. Structurally modified ibogaine analogs exhibit differing affinities for NMDA receptors. European Journal of Pharmacology. 309: 159-65. PMID 8874134 DOI: 10.1016/0014-2999(96)00304-4  0.664
1996 Skolnick P, Layer RT, Popik P, Nowak G, Paul IA, Trullas R. Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry. 29: 23-6. PMID 8852530 DOI: 10.1055/S-2007-979537  0.753
1995 Popik P, Lewin A, Berrang B, Nowak G, Layer R, Skolnick P. [3H]1-aminocyclopropanecarboxylic acid, a novel probe for strychnine- insensitive glycine receptors. European Journal of Pharmacology. 291: 221-7. PMID 8719405 DOI: 10.1016/0922-4106(95)90061-6  0.635
1995 Layer RT, Popik P, Olds T, Skolnick P. Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715). Pharmacology, Biochemistry, and Behavior. 52: 621-7. PMID 8545484 DOI: 10.1016/0091-3057(95)00155-P  0.731
1995 Popik P, Layer RT, Skolnick P. 100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug. Pharmacological Reviews. 47: 235-53. PMID 7568327  0.558
1995 Popik P, Layer RT, Fossom LH, Benveniste M, Geter-Douglass B, Witkin JM, Skolnick P. NMDA antagonist properties of the putative antiaddictive drug, ibogaine. The Journal of Pharmacology and Experimental Therapeutics. 275: 753-60. PMID 7473163  0.712
1994 Paul IA, Nowak G, Layer RT, Popik P, Skolnick P. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. The Journal of Pharmacology and Experimental Therapeutics. 269: 95-102. PMID 8169857  0.744
1994 Popik P, Layer RT, Skolnick P. The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex. Psychopharmacology. 114: 672-4. PMID 7531855 DOI: 10.1007/Bf02245000  0.713
1993 Layer RT, Kaddis FG, Wallace LJ. The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats. Pharmacology, Biochemistry, and Behavior. 44: 245-7. PMID 8430127 DOI: 10.1016/0091-3057(93)90306-E  0.643
1993 Layer RT, Uretsky NJ, Wallace LJ. Effects of the AMPA/kainate receptor antagonist DNQX in the nucleus accumbens on drug-induced conditioned place preference. Brain Research. 617: 267-73. PMID 8402155 DOI: 10.1016/0006-8993(93)91094-9  0.637
1993 Layer RT, Bland LR, Skolnick P. MK-801, but not drugs acting at strychnine-insensitive glycine receptors, attenuate methamphetamine nigrostriatal toxicity. Brain Research. 625: 38-44. PMID 8242398 DOI: 10.1016/0006-8993(93)90135-A  0.63
1993 Nowak G, Trullas R, Layer RT, Skolnick P, Paul IA. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. The Journal of Pharmacology and Experimental Therapeutics. 265: 1380-6. PMID 8099620  0.767
1993 Paul IA, Layer RT, Skolnick P, Nowak G. Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine. European Journal of Pharmacology. 247: 305-11. PMID 7905831 DOI: 10.1016/0922-4106(93)90199-J  0.749
1992 Layer RT, Uretsky NJ, Wallace LJ. Effect of serotonergic agonists in the nucleus accumbens on d-amphetamine-stimulated locomotion. Life Sciences. 50: 813-20. PMID 1740965 DOI: 10.1016/0024-3205(92)90187-T  0.551
1992 Boldry RC, Layer RT, Wallace LJ, Uretsky NJ. Stimulation of locomotor activity by intra-accumbens AMPA is not inhibited by neonatal 6-hydroxydopamine-induced lesions. Neuroscience Letters. 138: 265-9. PMID 1376874 DOI: 10.1016/0304-3940(92)90930-6  0.572
1991 Layer RT, Uretsky NJ, Wallace LJ. Effects of morphine in the nucleus accumbens on stimulant-induced locomotion. Pharmacology, Biochemistry, and Behavior. 40: 21-6. PMID 1685784 DOI: 10.1016/0091-3057(91)90315-S  0.599
Show low-probability matches.